Entourage Health Reports Second Quarter 2024 Financial Results

• The total revenue of $12.2 million underscores the company’s solid year-over-year momentum and continued growth in the fast-growing bulk sales market.
• Entourage made a strong impression with the launch of new products in Alberta, Ontario and British Columbia, including the extensive flower offering from Color Cannabis.
• Dime Bag continued its strong performance in Ontario, with sequential sales growth and a distribution milestone of over 90% coverage.
• Entourage continues to deliver positive results thanks to its restructuring initiatives, with selling, general and administrative expenses showing a year-on-year decrease.
• Management will hold a conference call on August 27, 2024 at 10:00 a.m. Eastern Time.

TORONTO, August 27, 2024 (GLOBE NEWSWIRE) — Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) “Entourage” or the “Companya Canadian producer and distributor of award-winning cannabis products, today announced financial results for the three months and six months ended June 30, 2024. The Company reported total revenues of $12.2 million (net revenues of $9.3 million, before excise taxes and rebates). The Company will host a conference call on Tuesday, August 27, 2024 at 10:00 a.m. Eastern Time to discuss financial and business highlights.

“Overall, our performance so far this year has been consistent with our expectations and prior performance. As we move into Q3 and beyond, we are optimistic about the opportunities ahead,” said George Scorsis, CEO and Chairman. “This quarter, we focused on launching new products and offerings across our Entourage brands. The Dime Bag expansion saw significant traction, reaching over 90% distribution in Ontario. We remain committed to providing variety to our consumers and are confident that these efforts will lead to improved financial results as we progress through the year.”